VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV was delisted on the 7th of August, 2024.
70 hedge funds and large institutions have $58.8M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2019 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 23 increasing their positions, 9 reducing their positions, and 7 closing their positions.
200% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 7
156% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 9
25% more funds holding
Funds holding: 56 → 70 (+14)
19% more capital invested
Capital invested by funds: $49.4M → $58.8M (+$9.45M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$14M |
| 2 |
6CM
683 Capital Management
New York
|
+$1.4M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.11M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$934K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
+$612K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FI
Fosun International
Hong Kong,
China
|
-$1.16M |
| 2 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
-$776K |
| 3 |
Goldman Sachs
New York
|
-$643K |
| 4 |
Blackstone Inc
New York
|
-$576K |
| 5 |
Jane Street
New York
|
-$81K |
VBIV Hedge Fund Activity: Q3 2019 in Review
70 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) for Q3 2019, worth a combined $58.8M — up 19% from $49.4M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new VBIV positions and 7 closed out — a net gain of 14 holders — while 23 added to existing stakes and 9 trimmed.
The largest buyer was Perceptive Advisors, adding an estimated $14M. The largest seller was Fosun International, exiting entirely with an estimated $1.16M sold.
- 70 institutional investors held VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) as of Q3 2019, up from 56 in Q2 2019.
- Funds reported $58.8M of VBI Vaccines, Inc. New Common Stock (Canada) stock for Q3 2019, up 19% quarter-over-quarter.
- 21 funds opened new VBI Vaccines, Inc. New Common Stock (Canada) positions in Q3 2019 and 7 closed out, a net change of +14 holders.
- The largest VBI Vaccines, Inc. New Common Stock (Canada) buyer in Q3 2019 was Perceptive Advisors, an estimated $14M added.
- The largest VBI Vaccines, Inc. New Common Stock (Canada) seller in Q3 2019 was Fosun International, an estimated $1.16M sold.
Based on aggregated 13F filings for Q3 2019.